Robert J. Gould, Director of Fulcrum Therapeutics FULC, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $667.4K. The latest trade was on 02/02.

RG

RG

Robert J. Gould

Director

Company

Fulcrum Therapeutics FULC

First filing

23/01/13

Trades

9 trades

Buys / sales

0 / 5

12-month net buying

−$667.4K

Last trade

02/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Fulcrum TherapeuticsFULC	Open-market saleAmendment	01/02–02/02	02/04	30,000 sh2 trades	$10.80avg.	$323,850	−6.2%
Fulcrum TherapeuticsFULC	Open-market sale	01/02	01/06	15,000 sh	$11.87	$178,050	−3.1%
Fulcrum TherapeuticsFULC	Open-market sale	25/11/19	25/11/21	15,000 sh	$11.03	$165,450	−3.0%
Fulcrum TherapeuticsFULC	Open-market sale	23/01/13	23/01/13	6,766 sh	$15.00	$101,490	−1.3%